Answers are grounded in this paper and cite their sources.
CRISPR-Cas genome editing technology, originally derived from the adaptive immune system of bacteria, has expanded its applications to a wide range of organisms. Despite its broad applicability, several technical challenges still limit the precision and versatility of CRISPR-Cas systems. In this review, we systematically discuss technological advances developed to overcome these limitations. We examine the engineering of Cas orthologs to expand the target recognition range and improve targeting specificity, as well as guide RNA (gRNA) modification that enhance editing efficiency and specificity. We also highlight recent applications of advanced CRISPR-Cas technologies in crop improvement, probiotic and microbial engineering, and pathogen diagnostics. Finally, we discuss the growing role of computational and artificial intelligence (AI)-assisted approaches in gRNA design, Cas protein engineering, and the optimization of base and prime editing systems. Overall, this review provides an integrated overview of current engineering strategies, their emerging biotechnological applications, and future AI-assisted approaches that will accelerate precision genome editing across diverse biological systems.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: